Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models

Journal of Magnetic Resonance Imaging

Volumn 40, Issue 5, 2014, Pages 1071-1081

  Wang, Liya ^a   Zhong, Xiaodong ^b   Qian, Weiping ^a   Huang, Jing ^a   Cao, Zehong ^a   Yu, Qiqi ^a   Lipowska, Malgorzata ^a   Lin, Run ^a   Wang, Andrew ^c   Yang, Lily ^a   Mao, Hui ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SIEMENS CORPORATE RESEARCH   (United States)

^c OCEAN NANOTECH LLC   (United States)

Author keywords

Magnetic nanoparticle; Magnetic resonance imaging; Molecular imaging; Positive contrast; Targeted contrast agent; Ultrashort echo time

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FERRIC FERROCYANIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UROKINASE; CONTRAST MEDIUM; MAGNETITE NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; COMPUTER SIMULATION; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; CONTRAST TO NOISE RATIO; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG BINDING; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMAGE PROCESSING; IMAGE SUBTRACTION; IMAGING PHANTOM; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PANCREAS CANCER; SENSITIVITY AND SPECIFICITY; TARGET ORGAN; TISSUE SECTION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT; ULTRASHORT ECHO TIME IMAGING; ANIMAL; CANCER TRANSPLANTATION; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; MAMMARY NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; PROCEDURES; THREE DIMENSIONAL IMAGING; XENOGRAFT;

ANIMALS; CONTRAST MEDIA; FEMALE; HETEROGRAFTS; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; IN VITRO TECHNIQUES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MOLECULAR IMAGING; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; PHANTOMS, IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 84913613777     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24453     Document Type: Article

References (41)

1. Peng XH, Qian X, Mao H, et al. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomed 2008;3:311-321.
2. Tassa C, Shaw SY, Weissleder R. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res 2011;44:842- 852.
3. Weinstein JS, Varallyay CG, Dosa E, et al. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 2010;30:15-35.
4. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 1999;10:186-191.
5. Lewin M, Carlesso N, Tung CH, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000;18:410-414.
6. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005;5:161-171.
7. Joshi BP, Wang TD. Exogenous molecular probes for targeted imaging in cancer: focus on multi-modal imaging. Cancers (Basel) 2010;2:1251-1287.
8. Qiao J, Li S, Wei L, et al. HER2 targeted molecular MR imaging using a de novo designed protein contrast agent. PLoS One 2011; 6:e18103.
9. Sun C, Lee JS, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008;60:1252-1265.
10. Yang L, Mao H, Cao Z, et al. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. Gastroenterology 2009;136:1514-1525.
11. Hadjipanayis CG, Machaidze R, Kaluzova M, et al. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res 2010;70:6303-6312.
12. Bae WC, Du J, Bydder GM, Chung CB. Conventional and ultrashort time-to-echo magnetic resonance imaging of articular cartilage, meniscus, and intervertebral disk. Top Magn Reson Imaging 2010;21:275-289.
13. Chambon C, Clement O, Le Blanche A, Schouman-Claeys E, Frija G. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn Reson Imaging 1993; 11:509-519.
14. Simon GH, Bauer J, Saborovski O, et al. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning. Eur Radiol 2006;16:738-745.
15. Korosoglou G, Weiss RG, Kedziorek DA, et al. Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J Am Coll Cardiol 2008;52:483-491.
16. Stuber M, Gilson WD, Schar M, et al. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med 2007; 58:1072-1077.
17. Shapiro EM, Skrtic S, Koretsky AP. Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn Reson Med 2005; 53:329-338.
18. Zhang L, Zhong X, Wang L, et al. T(1)-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles. J Magn Reson Imaging 2011;33:194-202.
19. Cunningham CH, Arai T, Yang PC, McConnell MV, Pauly JM, Conolly SM. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005;53: 999-1005.
20. Zurkiya O, Hu X. Off-resonance saturation as a means of generating contrast with superparamagnetic nanoparticles. Magn Reson Med 2006;56:726-732.
21. Nofiele JT, Cheng HL. Ultrashort echo time for improved positivecontrast manganese-enhanced MRI of cancer. PLoS One 2013;8: e58617.
22. Girard OM, Du J, Agemy L, et al. Optimization of iron oxide nanoparticle detection using ultrashort echo time pulse sequences: comparison of T1, T2∗, and synergistic T1-T2∗ contrast mechanisms. Magn Reson Med 2011;65:1649-1660.
23. Khemtong C, Kessinger CW, Ren J, et al. In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles. Cancer Res 2009;69:1651- 1658.
24. Idiyatullin D, Corum C, Park JY, Garwood M. Fast and quiet MRI using a swept radiofrequency. J Magn Reson 2006;181:342-349.
25. Kendi AT, Khariwala SS, Zhang J, et al. Transformation in mandibular imaging with sweep imaging with fourier transform magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 2011; 137:916-919.
26. Zhou R, Idiyatullin D, Moeller S, et al. SWIFT detection of SPIOlabeled stem cells grafted in the myocardium. Magn Reson Med 2010;63:1154-1161.
27. Lehto LJ, Sierra A, Corum CA, et al. Detection of calcifications in vivo and ex vivo after brain injury in rat using SWIFT. Neuroimage 2012;61:761-772.
28. Markl M, Chan FP, Alley MT, et al. Time-resolved threedimensional phase-contrast MRI. J Magn Reson Imaging 2003; 17:499-506.
29. Srichai MB, Lim RP, Wong S, Lee VS. Cardiovascular applications of phase-contrast MRI. AJR Am J Roentgenol 2009;192:662-675.
30. Zhao Q, Langley J, Lee S, Liu W. Positive contrast technique for the detection and quantification of superparamagnetic iron oxide nanoparticles in MRI. NMR Biomed 2011;24:464-472.
31. de Graaf, RA, Rothman DL, Behar KL. Adiabatic RARE imaging. NMR Biomed 2003;16:29-35.
32. Harris SS, Mao H, Hu XP. Adiabatic pulse preparation for imaging iron oxide nanoparticles. Magn Reson Med 2012;67:1133- 1137.
33. Duan HW, Kuang M, Wang XX, Wang YA, Mao H, Nie SM. Reexamining the effects of particle size and surface chemistry on the magnetic properties of iron oxide nanocrystals: new insights into spin disorder and proton relaxivity. J Phys Chem C 2008;112: 8127-8131.
34. Chen H, Wang L, Yeh J, Wu X, Cao Z, Wang YA, et al. Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PgMPS copolymer coating. Biomaterials 2010;31:5397-5407.
35. Zhou Z, Chen H, Lipowska M, et al. A dual-modal magnetic nanoparticle probe for preoperative and intraoperative mapping of sentinel lymph nodes by magnetic resonance and near infrared fluorescence imaging. J Biomater Appl 2013;28:100-111.
36. Suzuki Y, Cunningham CH, Noguchi K, et al. In vivo serial evaluation of superparamagnetic iron-oxide labeled stem cells by offresonance positive contrast. Magn Reson Med 2008;60:1269-1275.
37. Yang L, Mao H, Wang YA, et al. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small 2009;5:235-243.
38. Yang L, Peng XH, Wang YA, et al. Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin Cancer Res 2009;15: 4722-4732.
39. Hirsch NM, Preibisch C. T2∗ mapping with background gradient correction using different excitation pulse shapes. AJNR Am J Neuroradiol 2013;34:65-68.
40. Lu Y, Yang J, Sega E. Issues related to targeted delivery of proteins and peptides. AAPS J 2006;8:466-478.
41. Du J, Takahashi AM, Bae WC, Chung CB, Bydder GM. Dual inversion recovery, ultrashort echo time (DIR UTE) imaging: creating high contrast for short-T(2) species. Magn Reson Med 2010; 63:447-455.